Antibiotic prophylaxis and infection risk in pediatric ventriculoperitoneal shunt surgery: a systematic review and

Ibrahim Alnaami1, Majed Aldehri2,3, Ayman Bahatheq4

  • 1Division of Neurosurgery, Department of Surgery, College of Medicine, King Khalid University, Abha, Saudi Arabia.

PubMed

Insights

Antibiotic prophylaxis, especially vancomycin, significantly lowers infection rates in pediatric ventriculoperitoneal (VP) shunt surgery. However, caution is advised due to study limitations and heterogeneity in practice.

Area of Science:

  • Neurosurgery
  • Infectious Disease Prevention
  • Pediatric Medicine

Background:

  • Ventriculoperitoneal (VP) shunt infection is a significant complication in pediatric hydrocephalus management.
  • Effective antimicrobial strategies for preventing shunt infections are crucial but debated.
  • Optimal antibiotic selection for reducing VP shunt infections requires further investigation.

Purpose of the Study:

  • To systematically review and meta-analyze the evidence on antibiotic prophylaxis efficacy in reducing surgical site infections (SSIs) in pediatric VP shunt surgery.
  • To evaluate the impact of different antibiotic types on infection rates.
  • To provide insights into current practices for infection control in pediatric neurosurgery.

Main Methods:

  • Systematic literature search of multiple databases (PubMed, EMBASE, Cochrane Library, etc.) from 1975 to June 2025.
  • Inclusion of 11 studies (8 RCTs, 3 retrospective cohorts) with 2379 pediatric patients (<18 years).
  • Meta-analysis of infection risk using risk ratios (RR) and 95% confidence intervals (CI), with subgroup analyses by antibiotic type and study design.

Main Results:

  • The pooled infection rate in patients receiving antibiotics was 6.3%.
  • Prophylactic antibiotics significantly reduced the risk of infection (RR=0.55, P=0.0016).
  • Vancomycin showed a significant reduction in infection risk (RR=0.51, P=0.03), while methicillin and other antibiotics did not reach statistical significance.

Conclusions:

  • Antibiotic prophylaxis, particularly vancomycin, is effective in reducing infection rates for pediatric VP shunt surgery.
  • Findings suggest potential benefits but require cautious interpretation due to heterogeneity in study designs, infection definitions, and antibiotic regimens.
  • Results cannot be directly extrapolated to contemporary clinical practice without further research addressing current standards.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377